During the past decade, Retina Group of Florida conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 12 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 8 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Retina Group of Florida" #1 sponsor was "Hoffmann-La Roche" with 7 trials, followed by "Clearside Biomedical, Inc." with 3 trials sponsored, "Jaeb Center for Health Research" with 3 trials sponsored, "Bayer" with 1 trials sponsored and "Eyetech Pharmaceuticals" with 1 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Retina Group of Florida" #1 collaborator was "National Eye Institute (NEI)" with 5 trials as a collaborator, "Regeneron Pharmaceuticals" with 3 trials as a collaborator, "Juvenile Diabetes Research Foundation" with 2 trials as a collaborator, "Allergan" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Retina Group of Florida" are "Diabetic Macular Edema" (7 trials), "Geographic Atrophy" (6 trials), "Panuveitis" (3 trials), "Uveitis" (3 trials) and "Uveitis, Anterior" (3 trials). Many other conditions were trialed in "Retina Group of Florida" in a lesser frequency.

Most popular intervention types in "Retina Group of Florida" are "Drug" (24 trials), "Other" (5 trials), "Procedure" (4 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Sham Procedure" (5 trials), "Faricimab" (4 trials), "ranibizumab" (3 trials), "4 mg CLS-TA Suprachoriodal Injection" (2 trials) and "Aflibercept" (2 trials). Other intervention names were less common.

The vast majority of trials in "Retina Group of Florida" are 26 trials for "All" genders.

Currently, there are NaN active trials in "Retina Group of Florida". undefined are not yet recruiting, undefined are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Retina Group of Florida, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Retina Group of Florida, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".